 | |
| Clinical data | |
|---|---|
|
Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard ( EPA) | |
| Chemical and physical data | |
| Formula | C11H10ClNO3 |
| Molar mass | 239.66 g·mol−1 |
| 3D model ( JSmol) | |
| |
Meseclazone (W-2395), also known as 2-methylseclazone, is a nonsteroidal anti-inflammatory drug (NSAID) developed in the 1970s. [1] [2] It functions as a prodrug to the 5- chloro derivative of salicyclic acid. [2] It was never marketed on account of toxicity issues, namely pertaining to the liver. [2]
- ^ Dictionary of organic compounds. London: Chapman & Hall. 1996. ISBN 0-412-54090-8.
- ^ a b c Rainsford KD (2004). Aspirin and related drugs. Washington, DC: Taylor & Francis. ISBN 0-7484-0885-1.
|
pyrazolones / pyrazolidines | |
|---|---|
| salicylates | |
|
acetic acid derivatives and related substances | |
| oxicams | |
|
propionic acid derivatives ( profens) |
|
| n-arylanthranilic acids ( fenamates) | |
|
COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #
WHO-Essential Medicines; †
withdrawn drugs; ‡
veterinary use. | |
|
| |
| Clinical data | |
|---|---|
|
Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard ( EPA) | |
| Chemical and physical data | |
| Formula | C11H10ClNO3 |
| Molar mass | 239.66 g·mol−1 |
| 3D model ( JSmol) | |
| |
Meseclazone (W-2395), also known as 2-methylseclazone, is a nonsteroidal anti-inflammatory drug (NSAID) developed in the 1970s. [1] [2] It functions as a prodrug to the 5- chloro derivative of salicyclic acid. [2] It was never marketed on account of toxicity issues, namely pertaining to the liver. [2]
- ^ Dictionary of organic compounds. London: Chapman & Hall. 1996. ISBN 0-412-54090-8.
- ^ a b c Rainsford KD (2004). Aspirin and related drugs. Washington, DC: Taylor & Francis. ISBN 0-7484-0885-1.
|
pyrazolones / pyrazolidines | |
|---|---|
| salicylates | |
|
acetic acid derivatives and related substances | |
| oxicams | |
|
propionic acid derivatives ( profens) |
|
| n-arylanthranilic acids ( fenamates) | |
|
COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #
WHO-Essential Medicines; †
withdrawn drugs; ‡
veterinary use. | |